Rank | Gene Set | Z-score |
---|---|---|
1 | vocalization behavior (GO:0071625) | 6.01979084 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.93443923 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.82751365 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.71524169 |
5 | locomotory exploration behavior (GO:0035641) | 5.62840840 |
6 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.40218959 |
7 | synaptic vesicle exocytosis (GO:0016079) | 5.38961215 |
8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.33281280 |
9 | neuron cell-cell adhesion (GO:0007158) | 5.32794102 |
10 | protein localization to synapse (GO:0035418) | 5.28218513 |
11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.13957400 |
12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.13454171 |
13 | glutamate secretion (GO:0014047) | 5.00107881 |
14 | * glutamate receptor signaling pathway (GO:0007215) | 4.92559123 |
15 | synaptic vesicle maturation (GO:0016188) | 4.82602725 |
16 | exploration behavior (GO:0035640) | 4.82475333 |
17 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.79041942 |
18 | * synaptic transmission, glutamatergic (GO:0035249) | 4.72836377 |
19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.72586076 |
20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.63380660 |
21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60742277 |
22 | * neuron-neuron synaptic transmission (GO:0007270) | 4.54354522 |
23 | presynaptic membrane assembly (GO:0097105) | 4.44324229 |
24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.39256434 |
25 | neuronal action potential propagation (GO:0019227) | 4.36766477 |
26 | sodium ion export (GO:0071436) | 4.32338868 |
27 | positive regulation of synapse maturation (GO:0090129) | 4.28608730 |
28 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.27160705 |
29 | response to histamine (GO:0034776) | 4.22826203 |
30 | regulation of synaptic vesicle transport (GO:1902803) | 4.19921399 |
31 | postsynaptic membrane organization (GO:0001941) | 4.13573794 |
32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.09227512 |
33 | * regulation of postsynaptic membrane potential (GO:0060078) | 4.05302994 |
34 | positive regulation of membrane potential (GO:0045838) | 4.02281026 |
35 | long-term synaptic potentiation (GO:0060291) | 4.01283611 |
36 | neuron recognition (GO:0008038) | 4.01097300 |
37 | long-term memory (GO:0007616) | 4.00382797 |
38 | presynaptic membrane organization (GO:0097090) | 3.99228467 |
39 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.96387053 |
40 | neurotransmitter secretion (GO:0007269) | 3.96350804 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.96319781 |
42 | * regulation of synaptic plasticity (GO:0048167) | 3.92175777 |
43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91343479 |
44 | dendritic spine morphogenesis (GO:0060997) | 3.81583204 |
45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.81043486 |
46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.79558888 |
47 | L-amino acid import (GO:0043092) | 3.78095379 |
48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73246970 |
49 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.72806453 |
50 | axonal fasciculation (GO:0007413) | 3.72714931 |
51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.69376794 |
52 | innervation (GO:0060384) | 3.69276949 |
53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.67925362 |
54 | serotonin metabolic process (GO:0042428) | 3.62745550 |
55 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.62651049 |
56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.61177666 |
57 | * behavioral fear response (GO:0001662) | 3.55634071 |
58 | * behavioral defense response (GO:0002209) | 3.55634071 |
59 | cochlea development (GO:0090102) | 3.52290219 |
60 | neuronal ion channel clustering (GO:0045161) | 3.49165590 |
61 | gamma-aminobutyric acid transport (GO:0015812) | 3.47722724 |
62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.47120039 |
63 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.46109108 |
64 | layer formation in cerebral cortex (GO:0021819) | 3.44267517 |
65 | regulation of synapse maturation (GO:0090128) | 3.40017737 |
66 | nucleobase catabolic process (GO:0046113) | 3.39868499 |
67 | transmission of nerve impulse (GO:0019226) | 3.38564082 |
68 | synaptic vesicle endocytosis (GO:0048488) | 3.37702115 |
69 | response to auditory stimulus (GO:0010996) | 3.37550062 |
70 | regulation of dendritic spine development (GO:0060998) | 3.36686812 |
71 | * membrane depolarization (GO:0051899) | 3.35437590 |
72 | establishment of mitochondrion localization (GO:0051654) | 3.35185843 |
73 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.34809427 |
74 | proline transport (GO:0015824) | 3.33993530 |
75 | * learning (GO:0007612) | 3.32808999 |
76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.32245031 |
77 | cerebellar granule cell differentiation (GO:0021707) | 3.32102322 |
78 | cell communication by electrical coupling (GO:0010644) | 3.30772274 |
79 | * fear response (GO:0042596) | 3.29146490 |
80 | long term synaptic depression (GO:0060292) | 3.28840077 |
81 | regulation of neurotransmitter secretion (GO:0046928) | 3.26615819 |
82 | amino acid import (GO:0043090) | 3.26214389 |
83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25488295 |
84 | chemosensory behavior (GO:0007635) | 3.23836945 |
85 | cellular sodium ion homeostasis (GO:0006883) | 3.23753936 |
86 | cellular potassium ion homeostasis (GO:0030007) | 3.23227105 |
87 | regulation of vesicle fusion (GO:0031338) | 3.21005464 |
88 | neurotransmitter transport (GO:0006836) | 3.19624465 |
89 | membrane depolarization during action potential (GO:0086010) | 3.18713217 |
90 | cell communication involved in cardiac conduction (GO:0086065) | 3.18479338 |
91 | * startle response (GO:0001964) | 3.17806872 |
92 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.17190959 |
93 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.17121710 |
94 | regulation of female receptivity (GO:0045924) | 3.16676391 |
95 | dendritic spine organization (GO:0097061) | 3.15789386 |
96 | positive regulation of synapse assembly (GO:0051965) | 3.15771664 |
97 | neuronal action potential (GO:0019228) | 3.15384175 |
98 | positive regulation of synaptic transmission (GO:0050806) | 3.14118364 |
99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.10042256 |
100 | regulation of neurotransmitter transport (GO:0051588) | 3.09242486 |
101 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.09073714 |
102 | * synaptic transmission (GO:0007268) | 3.09024498 |
103 | * regulation of synaptic transmission (GO:0050804) | 3.09023491 |
104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.08897766 |
105 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.08155733 |
106 | regulation of glutamate secretion (GO:0014048) | 3.07907373 |
107 | membrane hyperpolarization (GO:0060081) | 3.07810593 |
108 | cell migration in hindbrain (GO:0021535) | 3.07520681 |
109 | positive regulation of dendritic spine development (GO:0060999) | 3.07480344 |
110 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06279245 |
111 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.05988821 |
112 | adult walking behavior (GO:0007628) | 3.05368135 |
113 | primary amino compound metabolic process (GO:1901160) | 3.04816768 |
114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04023907 |
115 | synapse assembly (GO:0007416) | 3.03778189 |
116 | mechanosensory behavior (GO:0007638) | 3.02626384 |
117 | potassium ion homeostasis (GO:0055075) | 3.02017228 |
118 | auditory behavior (GO:0031223) | 3.01902239 |
119 | neuromuscular process controlling balance (GO:0050885) | 3.00443054 |
120 | negative regulation of dendrite development (GO:2000171) | 3.00143735 |
121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.00051285 |
122 | dendrite morphogenesis (GO:0048813) | 2.98741758 |
123 | activation of protein kinase A activity (GO:0034199) | 2.98093986 |
124 | behavioral response to cocaine (GO:0048148) | 2.97746624 |
125 | central nervous system neuron axonogenesis (GO:0021955) | 2.97515006 |
126 | regulation of neurotransmitter levels (GO:0001505) | 2.97371149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.52804134 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.53712520 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12143592 |
4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06333321 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02430315 |
6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65737445 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64052397 |
8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52704957 |
9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52704957 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50008123 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49829605 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42223463 |
13 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.42075124 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35888830 |
15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35011209 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33977140 |
17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32832843 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32123042 |
19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.25629307 |
20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16958915 |
21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16050313 |
22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.13088050 |
23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06419822 |
24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05494590 |
25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03109295 |
26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01231919 |
27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96595732 |
28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95868714 |
29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94811719 |
30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.92090190 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89103516 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82446501 |
33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80502902 |
34 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.75422652 |
35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71522966 |
36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69441389 |
37 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61655355 |
38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60716018 |
39 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53954525 |
40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48486334 |
41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46446564 |
42 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46172711 |
43 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.44043163 |
44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42635558 |
45 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.40837096 |
46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39596872 |
47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39337992 |
48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38861107 |
49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38545479 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38507368 |
51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37862429 |
52 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37803875 |
53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37583087 |
54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36348648 |
55 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36133966 |
56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35681729 |
57 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34707815 |
58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31428649 |
59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28505515 |
60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28149263 |
61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26183455 |
62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25919130 |
63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24962598 |
64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24147845 |
65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22831060 |
66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22564987 |
67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21920150 |
68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20175555 |
69 | AR_19668381_ChIP-Seq_PC3_Human | 1.20057480 |
70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19144724 |
71 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19119605 |
72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18302803 |
73 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16819369 |
74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15714861 |
75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15541153 |
76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15331247 |
77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14497046 |
78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13929516 |
79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11181906 |
80 | JUN_21703547_ChIP-Seq_K562_Human | 1.10696351 |
81 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10660777 |
82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10371446 |
83 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10198891 |
84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10023646 |
85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09278926 |
86 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08667714 |
87 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08449618 |
88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07342502 |
89 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06786202 |
90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06494778 |
91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06417242 |
92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05531967 |
93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05210228 |
94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04747612 |
95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04747612 |
96 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03988416 |
97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03581940 |
98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02257292 |
99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01330209 |
100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99890670 |
101 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99890670 |
102 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98665760 |
103 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98422805 |
104 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98356113 |
105 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97316345 |
106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97002609 |
107 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96799820 |
108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96611745 |
109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96600766 |
110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96473526 |
111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94284766 |
112 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93872762 |
113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93113999 |
114 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.92720785 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0004859_abnormal_synaptic_plasticity | 6.73395304 |
2 | MP0003880_abnormal_central_pattern | 5.61135489 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.38522069 |
4 | MP0004270_analgesia | 4.02570873 |
5 | MP0009745_abnormal_behavioral_response | 3.72317685 |
6 | * MP0002063_abnormal_learning/memory/cond | 3.63985047 |
7 | MP0002064_seizures | 3.31651110 |
8 | MP0001968_abnormal_touch/_nociception | 3.26579083 |
9 | * MP0002572_abnormal_emotion/affect_behav | 3.07163709 |
10 | MP0009046_muscle_twitch | 2.95949535 |
11 | MP0002736_abnormal_nociception_after | 2.66430582 |
12 | MP0002272_abnormal_nervous_system | 2.65430754 |
13 | MP0002822_catalepsy | 2.57157596 |
14 | MP0001486_abnormal_startle_reflex | 2.54821008 |
15 | MP0002735_abnormal_chemical_nociception | 2.50620305 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.48211484 |
17 | MP0001501_abnormal_sleep_pattern | 2.45766215 |
18 | MP0001440_abnormal_grooming_behavior | 2.27673543 |
19 | MP0005423_abnormal_somatic_nervous | 2.25553795 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.06974064 |
21 | MP0002067_abnormal_sensory_capabilities | 2.03578871 |
22 | MP0003879_abnormal_hair_cell | 1.92919651 |
23 | MP0000778_abnormal_nervous_system | 1.92319353 |
24 | MP0003787_abnormal_imprinting | 1.90743244 |
25 | MP0002733_abnormal_thermal_nociception | 1.87274544 |
26 | MP0001970_abnormal_pain_threshold | 1.84164468 |
27 | MP0002184_abnormal_innervation | 1.81797071 |
28 | MP0005646_abnormal_pituitary_gland | 1.76960518 |
29 | MP0005386_behavior/neurological_phenoty | 1.73862199 |
30 | MP0004924_abnormal_behavior | 1.73862199 |
31 | MP0002557_abnormal_social/conspecific_i | 1.73225418 |
32 | MP0004811_abnormal_neuron_physiology | 1.70476431 |
33 | MP0008569_lethality_at_weaning | 1.65351587 |
34 | MP0001529_abnormal_vocalization | 1.63558043 |
35 | MP0001188_hyperpigmentation | 1.61977049 |
36 | MP0003329_amyloid_beta_deposits | 1.59093900 |
37 | MP0006276_abnormal_autonomic_nervous | 1.58864699 |
38 | MP0001984_abnormal_olfaction | 1.48300148 |
39 | MP0004858_abnormal_nervous_system | 1.43106048 |
40 | MP0002909_abnormal_adrenal_gland | 1.43036003 |
41 | * MP0002066_abnormal_motor_capabilities/c | 1.37987061 |
42 | MP0000955_abnormal_spinal_cord | 1.36009178 |
43 | * MP0002882_abnormal_neuron_morphology | 1.33507835 |
44 | MP0001905_abnormal_dopamine_level | 1.30654409 |
45 | MP0005645_abnormal_hypothalamus_physiol | 1.21531692 |
46 | * MP0003633_abnormal_nervous_system | 1.20445531 |
47 | MP0004885_abnormal_endolymph | 1.14278756 |
48 | MP0003121_genomic_imprinting | 1.13246978 |
49 | MP0004142_abnormal_muscle_tone | 1.11901579 |
50 | MP0001502_abnormal_circadian_rhythm | 1.10807522 |
51 | * MP0002152_abnormal_brain_morphology | 1.07569051 |
52 | MP0002837_dystrophic_cardiac_calcinosis | 1.06737141 |
53 | * MP0003631_nervous_system_phenotype | 1.04226645 |
54 | MP0003122_maternal_imprinting | 1.02132211 |
55 | MP0008872_abnormal_physiological_respon | 1.01707300 |
56 | MP0002638_abnormal_pupillary_reflex | 1.00956661 |
57 | MP0000569_abnormal_digit_pigmentation | 1.00225009 |
58 | MP0002876_abnormal_thyroid_physiology | 0.96397924 |
59 | MP0010386_abnormal_urinary_bladder | 0.95362148 |
60 | MP0004145_abnormal_muscle_electrophysio | 0.93951321 |
61 | MP0004085_abnormal_heartbeat | 0.92064740 |
62 | MP0000751_myopathy | 0.92044562 |
63 | * MP0002069_abnormal_eating/drinking_beha | 0.91497736 |
64 | MP0001963_abnormal_hearing_physiology | 0.90513953 |
65 | MP0004484_altered_response_of | 0.90107112 |
66 | MP0004510_myositis | 0.87932866 |
67 | MP0005409_darkened_coat_color | 0.87877127 |
68 | * MP0008874_decreased_physiological_sensi | 0.84754967 |
69 | MP0004215_abnormal_myocardial_fiber | 0.84208926 |
70 | MP0002229_neurodegeneration | 0.84143291 |
71 | MP0005187_abnormal_penis_morphology | 0.82515664 |
72 | MP0004147_increased_porphyrin_level | 0.82455008 |
73 | MP0001177_atelectasis | 0.81090766 |
74 | MP0004742_abnormal_vestibular_system | 0.80539362 |
75 | MP0003123_paternal_imprinting | 0.80134025 |
76 | MP0005551_abnormal_eye_electrophysiolog | 0.80058803 |
77 | MP0005535_abnormal_body_temperature | 0.74534625 |
78 | MP0001664_abnormal_digestion | 0.72600072 |
79 | MP0001485_abnormal_pinna_reflex | 0.72384312 |
80 | MP0000631_abnormal_neuroendocrine_gland | 0.71913462 |
81 | MP0005171_absent_coat_pigmentation | 0.71820818 |
82 | MP0003075_altered_response_to | 0.70698704 |
83 | MP0003119_abnormal_digestive_system | 0.69418872 |
84 | MP0003632_abnormal_nervous_system | 0.69264182 |
85 | MP0001986_abnormal_taste_sensitivity | 0.68795356 |
86 | MP0002752_abnormal_somatic_nervous | 0.67964138 |
87 | MP0002102_abnormal_ear_morphology | 0.67256226 |
88 | MP0005499_abnormal_olfactory_system | 0.66767666 |
89 | MP0005394_taste/olfaction_phenotype | 0.66767666 |
90 | MP0000604_amyloidosis | 0.65271371 |
91 | MP0004043_abnormal_pH_regulation | 0.62689111 |
92 | MP0002234_abnormal_pharynx_morphology | 0.60259567 |
93 | MP0004130_abnormal_muscle_cell | 0.60026555 |
94 | MP0006292_abnormal_olfactory_placode | 0.59801304 |
95 | MP0003890_abnormal_embryonic-extraembry | 0.58866360 |
96 | MP0002751_abnormal_autonomic_nervous | 0.57963142 |
97 | MP0000026_abnormal_inner_ear | 0.57833791 |
98 | MP0003634_abnormal_glial_cell | 0.57828220 |
99 | MP0008877_abnormal_DNA_methylation | 0.57658006 |
100 | MP0001299_abnormal_eye_distance/ | 0.55709837 |
101 | MP0000013_abnormal_adipose_tissue | 0.55279855 |
102 | MP0003938_abnormal_ear_development | 0.55030087 |
103 | MP0003861_abnormal_nervous_system | 0.53900737 |
104 | MP0004233_abnormal_muscle_weight | 0.53613260 |
105 | MP0001765_abnormal_ion_homeostasis | 0.52250990 |
106 | MP0001943_abnormal_respiration | 0.52152008 |
107 | * MP0010769_abnormal_survival | 0.50748661 |
108 | * MP0002082_postnatal_lethality | 0.50154618 |
109 | * MP0010770_preweaning_lethality | 0.50154618 |
110 | MP0003283_abnormal_digestive_organ | 0.49714370 |
111 | MP0003137_abnormal_impulse_conducting | 0.49401766 |
112 | MP0003956_abnormal_body_size | 0.49221340 |
113 | * MP0002081_perinatal_lethality | 0.49101029 |
114 | MP0005248_abnormal_Harderian_gland | 0.48925033 |
115 | * MP0010768_mortality/aging | 0.47816646 |
116 | MP0003690_abnormal_glial_cell | 0.47502161 |
117 | MP0000920_abnormal_myelination | 0.47288014 |
118 | MP0008961_abnormal_basal_metabolism | 0.47242797 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.83122707 |
2 | Myokymia (HP:0002411) | 6.44937229 |
3 | Focal seizures (HP:0007359) | 6.42664875 |
4 | Epileptic encephalopathy (HP:0200134) | 6.10087864 |
5 | Hyperventilation (HP:0002883) | 5.59189801 |
6 | Atonic seizures (HP:0010819) | 5.16906169 |
7 | Febrile seizures (HP:0002373) | 4.96849352 |
8 | Absence seizures (HP:0002121) | 4.83468714 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.63447559 |
10 | Dialeptic seizures (HP:0011146) | 4.55098328 |
11 | Visual hallucinations (HP:0002367) | 4.54993632 |
12 | Broad-based gait (HP:0002136) | 4.38996765 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 4.17480799 |
14 | Gaze-evoked nystagmus (HP:0000640) | 3.78415072 |
15 | Poor eye contact (HP:0000817) | 3.68417714 |
16 | Limb dystonia (HP:0002451) | 3.59632535 |
17 | Drooling (HP:0002307) | 3.53413777 |
18 | Excessive salivation (HP:0003781) | 3.53413777 |
19 | Amblyopia (HP:0000646) | 3.51651396 |
20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.46452289 |
21 | Epileptiform EEG discharges (HP:0011182) | 3.35249210 |
22 | Impaired social interactions (HP:0000735) | 3.28465614 |
23 | Abnormal social behavior (HP:0012433) | 3.28465614 |
24 | Truncal ataxia (HP:0002078) | 3.18146920 |
25 | Action tremor (HP:0002345) | 3.14938055 |
26 | Dysmetria (HP:0001310) | 3.11256428 |
27 | Dysdiadochokinesis (HP:0002075) | 3.04420660 |
28 | Absent speech (HP:0001344) | 3.01942366 |
29 | Genetic anticipation (HP:0003743) | 2.87526720 |
30 | Protruding tongue (HP:0010808) | 2.86927159 |
31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86563018 |
32 | Impaired smooth pursuit (HP:0007772) | 2.85772908 |
33 | Depression (HP:0000716) | 2.81353148 |
34 | Supranuclear gaze palsy (HP:0000605) | 2.80617687 |
35 | Anxiety (HP:0000739) | 2.76529954 |
36 | EEG with generalized epileptiform discharges (HP:0011198) | 2.74334907 |
37 | Scanning speech (HP:0002168) | 2.73918657 |
38 | Abnormal eating behavior (HP:0100738) | 2.68682629 |
39 | Inability to walk (HP:0002540) | 2.66794303 |
40 | Stereotypic behavior (HP:0000733) | 2.63880353 |
41 | Dysmetric saccades (HP:0000641) | 2.61734488 |
42 | Postural instability (HP:0002172) | 2.52354367 |
43 | Hypsarrhythmia (HP:0002521) | 2.52066371 |
44 | Diplopia (HP:0000651) | 2.49952282 |
45 | Abnormality of binocular vision (HP:0011514) | 2.49952282 |
46 | Impaired vibratory sensation (HP:0002495) | 2.46551806 |
47 | Blue irides (HP:0000635) | 2.44681588 |
48 | Abnormality of the lower motor neuron (HP:0002366) | 2.44014999 |
49 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.42968075 |
50 | Mutism (HP:0002300) | 2.42259141 |
51 | Progressive inability to walk (HP:0002505) | 2.41525061 |
52 | Abnormality of salivation (HP:0100755) | 2.39976963 |
53 | Focal dystonia (HP:0004373) | 2.36087795 |
54 | Cerebral inclusion bodies (HP:0100314) | 2.34201998 |
55 | Hemiparesis (HP:0001269) | 2.34173611 |
56 | Termporal pattern (HP:0011008) | 2.33587355 |
57 | Insidious onset (HP:0003587) | 2.33587355 |
58 | Torticollis (HP:0000473) | 2.30817876 |
59 | Fair hair (HP:0002286) | 2.30082503 |
60 | Fetal akinesia sequence (HP:0001989) | 2.29983630 |
61 | Akinesia (HP:0002304) | 2.29852156 |
62 | Ankle clonus (HP:0011448) | 2.28967189 |
63 | Generalized myoclonic seizures (HP:0002123) | 2.27074674 |
64 | Bradykinesia (HP:0002067) | 2.26005975 |
65 | Papilledema (HP:0001085) | 2.25544077 |
66 | Urinary urgency (HP:0000012) | 2.25258050 |
67 | Generalized hypopigmentation of hair (HP:0011358) | 2.24704618 |
68 | Inappropriate behavior (HP:0000719) | 2.22121367 |
69 | Status epilepticus (HP:0002133) | 2.21593168 |
70 | Incomplete penetrance (HP:0003829) | 2.17692420 |
71 | Polyphagia (HP:0002591) | 2.13629745 |
72 | Spastic tetraplegia (HP:0002510) | 2.12051632 |
73 | Hepatoblastoma (HP:0002884) | 2.11768851 |
74 | Spastic gait (HP:0002064) | 2.08715057 |
75 | Thickened helices (HP:0000391) | 2.08293509 |
76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.07843463 |
77 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.07843463 |
78 | Sleep apnea (HP:0010535) | 2.07270625 |
79 | Abnormality of the corticospinal tract (HP:0002492) | 2.04104706 |
80 | Agitation (HP:0000713) | 2.02405456 |
81 | Gait ataxia (HP:0002066) | 2.02164088 |
82 | Widely spaced teeth (HP:0000687) | 2.01699262 |
83 | Neuroendocrine neoplasm (HP:0100634) | 2.00811823 |
84 | Neurofibrillary tangles (HP:0002185) | 2.00358269 |
85 | Prolonged QT interval (HP:0001657) | 1.96397308 |
86 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95357860 |
87 | Craniofacial dystonia (HP:0012179) | 1.92391326 |
88 | Gait imbalance (HP:0002141) | 1.92049332 |
89 | Hydroureter (HP:0000072) | 1.91540565 |
90 | Pheochromocytoma (HP:0002666) | 1.90531119 |
91 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.87706871 |
92 | Intention tremor (HP:0002080) | 1.86926804 |
93 | Hypoplasia of the corpus callosum (HP:0002079) | 1.84016899 |
94 | Clumsiness (HP:0002312) | 1.83800733 |
95 | Obstructive sleep apnea (HP:0002870) | 1.83307714 |
96 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80728069 |
97 | Exotropia (HP:0000577) | 1.79501228 |
98 | Lower limb amyotrophy (HP:0007210) | 1.78557465 |
99 | Gastroesophageal reflux (HP:0002020) | 1.78516913 |
100 | Psychosis (HP:0000709) | 1.78316954 |
101 | Hemiplegia (HP:0002301) | 1.78254107 |
102 | Intellectual disability, severe (HP:0010864) | 1.77249318 |
103 | Lower limb muscle weakness (HP:0007340) | 1.76388416 |
104 | Autism (HP:0000717) | 1.75792601 |
105 | Megalencephaly (HP:0001355) | 1.73463408 |
106 | Absent/shortened dynein arms (HP:0200106) | 1.71980301 |
107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71980301 |
108 | Spastic tetraparesis (HP:0001285) | 1.71540626 |
109 | Deeply set eye (HP:0000490) | 1.70991214 |
110 | Lissencephaly (HP:0001339) | 1.70843089 |
111 | Split foot (HP:0001839) | 1.70731751 |
112 | Delusions (HP:0000746) | 1.68854945 |
113 | Clonus (HP:0002169) | 1.68713643 |
114 | Specific learning disability (HP:0001328) | 1.68459425 |
115 | Syncope (HP:0001279) | 1.67662385 |
116 | Aqueductal stenosis (HP:0002410) | 1.66895218 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 5.34454151 |
2 | EPHA4 | 5.24360047 |
3 | CASK | 3.56494894 |
4 | MAP3K4 | 3.08358619 |
5 | MAP3K9 | 2.95912187 |
6 | MAP2K7 | 2.84544403 |
7 | MARK1 | 2.82333885 |
8 | RIPK4 | 2.53576117 |
9 | DAPK2 | 2.47859482 |
10 | MINK1 | 2.42942368 |
11 | MAP3K12 | 2.38787300 |
12 | TNIK | 1.99005672 |
13 | PLK2 | 1.92912169 |
14 | MAP2K4 | 1.89451970 |
15 | CDK19 | 1.81326164 |
16 | KSR1 | 1.80185946 |
17 | NTRK2 | 1.76834141 |
18 | PRPF4B | 1.76246670 |
19 | PAK6 | 1.68851264 |
20 | KSR2 | 1.59016459 |
21 | MAPK13 | 1.56237252 |
22 | CDK5 | 1.47670629 |
23 | CAMKK1 | 1.41497286 |
24 | FRK | 1.32202817 |
25 | SIK2 | 1.31189925 |
26 | * DAPK1 | 1.28839125 |
27 | AKT3 | 1.28039369 |
28 | PNCK | 1.27170538 |
29 | SIK3 | 1.24897251 |
30 | FES | 1.24228590 |
31 | PINK1 | 1.22972431 |
32 | PRKD3 | 1.22960101 |
33 | NTRK1 | 1.21982634 |
34 | * CAMK2A | 1.21963215 |
35 | BMPR2 | 1.18381762 |
36 | GRK5 | 1.15440914 |
37 | PTK2B | 1.14575169 |
38 | * PRKCG | 1.11442559 |
39 | CCNB1 | 1.07387988 |
40 | SGK2 | 1.04914466 |
41 | DYRK2 | 1.00466442 |
42 | * CAMK2B | 1.00264031 |
43 | OXSR1 | 0.96443252 |
44 | ARAF | 0.96436127 |
45 | CAMKK2 | 0.94689718 |
46 | STK38 | 0.94176975 |
47 | CDK18 | 0.92928365 |
48 | SGK223 | 0.92282778 |
49 | SGK494 | 0.92282778 |
50 | MAP3K2 | 0.92000153 |
51 | NME1 | 0.88955273 |
52 | RAF1 | 0.88104374 |
53 | CAMK1 | 0.86970152 |
54 | CDK15 | 0.85959203 |
55 | SGK1 | 0.84318255 |
56 | CDK14 | 0.83542085 |
57 | MAP3K13 | 0.79184345 |
58 | PKN1 | 0.77224419 |
59 | CDK11A | 0.74217932 |
60 | SGK3 | 0.73328290 |
61 | FGR | 0.69583159 |
62 | UHMK1 | 0.69492479 |
63 | STK11 | 0.68403480 |
64 | CSNK1A1L | 0.68079854 |
65 | PDK1 | 0.66370083 |
66 | EPHA3 | 0.65558047 |
67 | DYRK1A | 0.62172604 |
68 | PRKCE | 0.61573351 |
69 | MARK2 | 0.61326976 |
70 | CSNK1G2 | 0.60057751 |
71 | TYRO3 | 0.59498925 |
72 | PAK3 | 0.58388625 |
73 | MAP3K6 | 0.56975836 |
74 | BCR | 0.56772566 |
75 | MAP4K2 | 0.54810504 |
76 | LATS2 | 0.54736121 |
77 | CSNK1G3 | 0.54327900 |
78 | CAMK2D | 0.54190132 |
79 | PDPK1 | 0.52281333 |
80 | WNK3 | 0.51749965 |
81 | RET | 0.51535678 |
82 | TAOK1 | 0.51348269 |
83 | PHKG1 | 0.51146901 |
84 | PHKG2 | 0.51146901 |
85 | STK39 | 0.50163651 |
86 | FER | 0.49977471 |
87 | PRKCH | 0.49811572 |
88 | CSNK1D | 0.49695003 |
89 | BRAF | 0.49234659 |
90 | ADRBK2 | 0.46876868 |
91 | PRKCZ | 0.45809941 |
92 | INSRR | 0.45676293 |
93 | CSNK1G1 | 0.44907058 |
94 | MAP3K7 | 0.44880591 |
95 | * RPS6KA3 | 0.42650603 |
96 | MAPK12 | 0.42420259 |
97 | CAMK2G | 0.41528669 |
98 | ERBB3 | 0.39657290 |
99 | DMPK | 0.38142243 |
100 | DAPK3 | 0.37679366 |
101 | CAMK4 | 0.37543746 |
102 | TRIM28 | 0.37477878 |
103 | NEK6 | 0.37097768 |
104 | * FYN | 0.35234072 |
105 | MAP3K1 | 0.35218275 |
106 | MAP2K1 | 0.35201897 |
107 | CSNK1E | 0.35144354 |
108 | MAPK10 | 0.33248599 |
109 | CSNK1A1 | 0.33052150 |
110 | TNK2 | 0.31924583 |
111 | BMPR1B | 0.31651230 |
112 | ALK | 0.31592766 |
113 | CDK3 | 0.31135657 |
114 | GRK7 | 0.30942971 |
115 | CAMK1G | 0.29963068 |
116 | * PRKCB | 0.29548391 |
117 | GSK3B | 0.29224770 |
118 | PRKG1 | 0.29066054 |
119 | PRKACA | 0.28402111 |
120 | * PRKCA | 0.28094630 |
121 | ERBB2 | 0.27187116 |
122 | ROCK2 | 0.27070573 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Nicotine addiction_Homo sapiens_hsa05033 | 4.38307387 |
2 | * Long-term potentiation_Homo sapiens_hsa04720 | 3.08773476 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.03390697 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.00859098 |
5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.94335751 |
6 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.75826807 |
7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.75001014 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69129388 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.68004733 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62314127 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.40145739 |
12 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22740397 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 1.98841789 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96707303 |
15 | Taste transduction_Homo sapiens_hsa04742 | 1.96601577 |
16 | Renin secretion_Homo sapiens_hsa04924 | 1.90116217 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90029227 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88218007 |
19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.87725454 |
20 | Long-term depression_Homo sapiens_hsa04730 | 1.87054360 |
21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86996797 |
22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85090099 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75528648 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75055088 |
25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53664847 |
26 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.42175020 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41600511 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37803637 |
29 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33178153 |
30 | Gap junction_Homo sapiens_hsa04540 | 1.29348250 |
31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27330859 |
32 | Axon guidance_Homo sapiens_hsa04360 | 1.24844286 |
33 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24529909 |
34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19605939 |
35 | Glioma_Homo sapiens_hsa05214 | 1.16435167 |
36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15040165 |
37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14650574 |
38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12158200 |
39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09677063 |
40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06382458 |
41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06202897 |
42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05042422 |
43 | Melanogenesis_Homo sapiens_hsa04916 | 1.04170065 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00676454 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99160608 |
46 | Phototransduction_Homo sapiens_hsa04744 | 0.88749262 |
47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88717669 |
48 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87843253 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85719358 |
50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82980884 |
51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81171663 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77972198 |
53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75310421 |
54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72147871 |
55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69052715 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67900869 |
57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67873332 |
58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66185780 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65643591 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64716521 |
61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62821524 |
62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61727606 |
63 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.61682041 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60942399 |
65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58225904 |
66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53777778 |
67 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53583189 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53359992 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53098432 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51145169 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48432689 |
72 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46966129 |
73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46729102 |
74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46048091 |
75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44699956 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42594248 |
77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42409465 |
78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42380214 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42145353 |
80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41898126 |
81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41758099 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41371712 |
83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40230947 |
84 | Tight junction_Homo sapiens_hsa04530 | 0.40016289 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39086154 |
86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38883942 |
87 | * Alcoholism_Homo sapiens_hsa05034 | 0.37596782 |
88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34675569 |
89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32405453 |
90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30867581 |
91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30676186 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30175260 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30076075 |
94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29958842 |
95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29838110 |
96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29216411 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.29040623 |
98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28725371 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28653213 |
100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28546749 |
101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27785820 |
102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27568736 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27538099 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26787964 |
105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26284716 |
106 | Bile secretion_Homo sapiens_hsa04976 | 0.26195955 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.26103379 |
108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25372514 |
109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25133756 |
110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23132960 |
111 | Mineral absorption_Homo sapiens_hsa04978 | 0.20850197 |
112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.20805171 |